Skip to main content
Circio Holding ASA logo

Circio Holding ASA — Investor Relations & Filings

Ticker · CRNA ISIN · NO0013033795 LEI · 5967007LIEEXZXFYNS31 OL Professional, scientific and technical activities
Open in API
Filings indexed 170 across all filing types
Latest filing 2025-05-15 Major Shareholding Noti…
Country NO Norway
Listing OL CRNA

About Circio Holding ASA

https://www.targovax.com/en/

Circio Holding ASA is a clinical-stage company developing novel medicines based on circular RNA (circRNA) and immunotherapy. The company's core focus is its proprietary circVec platform, a circular RNA expression system designed to enhance the efficacy and durability of gene and cell therapies. Circio's development pipeline is directed towards immuno-oncology, targeting difficult-to-treat solid tumors, and the application of its circRNA technology to address genetic diseases.

Recent filings

Filing Released Lang Actions
Atlas Holdings for CIRCIO
Major Shareholding Notification Classification · 98% confidence The document explicitly mentions 'Pursuant to Securities Trading Regulation (STR), section 4-1' and details a change in ownership position for Atlas Special Opportunities, LLC in Circio Holding, providing specific figures for the start position, end of day position, and total outstanding shares based on transactions on May 14, 2025. This content directly relates to reporting changes in significant share ownership levels, which aligns perfectly with the definition of Major Shareholding Notification (MRQ). The document is short and reports a specific change event, not a comprehensive report.
2025-05-15 English
Atlas Holdings for CIRCIO
Major Shareholding Notification Classification · 98% confidence The document explicitly mentions 'Pursuant to Securities Trading Regulation (STR), section 4-1' and details a change in ownership percentage (from 1,969,622.00 to 5,006,295 shares, resulting in 5.2841% ownership). This structure—notifying a crossing of a notification threshold due to transactions—is characteristic of a Major Shareholding Notification, where an entity reports acquiring or disposing of shares that crosses a regulatory reporting threshold (like 5% or 10%). This aligns perfectly with the definition for Major Shareholding Notification (MRQ). The document length is very short, but the content is a direct notification of a holding change, not an announcement about another report.
2025-05-14 English
Circular RNA innovator Circio presents strengthened circVec gene therapy data at ASGCT 2025
Investor Presentation Classification · 98% confidence The document is a scientific poster presented at 'ASGCT 2025'. It details the development, optimization, and in vivo/in vitro performance of a novel circular RNA vector expression platform called 'circVec'. It includes detailed figures, experimental results (e.g., protein expression, stability, luminescence), and conclusions regarding its therapeutic potential. This content structure—detailed scientific findings, figures, and conclusions presented in a poster format—is characteristic of an Investor Presentation (IP) or a scientific abstract/presentation material, rather than a formal regulatory filing (like 10-K, ER, or IR). Since it is a detailed presentation of research findings aimed at an audience interested in the technology (investors, researchers), 'Investor Presentation' (IP) is the most appropriate classification.
2025-05-13 English
Circular RNA innovator Circio presents strengthened circVec gene therapy data at ASGCT 2025
Regulatory Filings Classification · 99% confidence The document is a press release from Circio Holding ASA announcing the presentation of new data at the ASGCT 2025 annual meeting. It details scientific findings (circVec gene therapy data) and concludes with a statement that 'The poster is attached to this press release and is available on Circio´s webpage'. This structure—a brief announcement detailing an event or publication and mentioning that the actual material (poster/presentation) is attached or linked—strongly indicates a Report Publication Announcement (RPA), as per Rule 2 (The 'MENU VS MEAL' Rule). It is not the full Annual Report (10-K), an Interim Report (IR), or a Call Transcript (CT).
2025-05-13 English
Circio Holding ASA - Funding requested under financing commitment from Atlas
Capital/Financing Update Classification · 98% confidence The document is a short announcement dated May 13, 2025, detailing that Circio Holding ASA has requested funding from Atlas under a previously established financing commitment. Specifically, it mentions requesting subscription for convertible bonds amounting to NOK 4,000,000. This action directly relates to the company's fundraising and capital structure management. Based on the definitions, this fits best under 'Capital/Financing Update' (CAP), as it is an immediate action regarding securing funds via debt instruments (convertible bonds). It is not a full report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), but a specific financing event announcement.
2025-05-13 English
Circio Holding ASA: Requested Conversion of Convertible Bonds
Capital/Financing Update Classification · 98% confidence The document explicitly details a 'Requested Conversion of Convertible Bonds' where an investor (Atlas) is converting debt into new shares. This action directly results in an increase in the company's share capital and the issuance of new shares. This falls squarely under the definition of 'Capital/Financing Update' (CAP), as it involves a change in the capital structure through debt-to-equity conversion. It is not an earnings release, a general report, or a director's dealing.
2025-05-13 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.